Aarti Pharma Labs

735.15
-18.75
(-2.49%)
ann
There are new updates from the company1 day ago
Viewcross
right
Market Cap
6,662.37 Cr
EPS
23.93
PE Ratio
27.42
Dividend Yield
0.40 %
Industry
Healthcare
52 Week High
837.25
52 Week Low
487.85
PB Ratio
3.68
Debt to Equity
0.15
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.13
36.71
#1 49,887.20
12.06
#1 9,648
13.77
59.27
6,012.50
1,59,612.98
79.83
8,184.00
0.89
1,600
#1 64.53
57.99
1,525.90
1,23,233.96
25.11
26,520.70
14.17
4,155
47.38
57.43
3,238.90
1,09,619.09
60.42
10,785.70
11.59
1,656
13.54
52.37
2,557.50
1,05,516.96
52.60
10,615.60
19.57
1,942
-16.38
59.98
1,174.80
98,031.82
#1 18.66
28,905.40
12.36
5,578
1.69
54.12
2,019.60
92,203.01
33.50
20,141.50
#1 19.94
1,936
38.82
50.28
859.65
86,500.90
19.53
19,831.50
13.82
3,831
29.92
46.44
1,220.10
70,863.61
20.72
29,559.20
17.55
3,169
-10.04
58.85
29,705.00
63,121.05
47.82
6,097.20
10.80
1,201
16.01
45.94

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-4.63 %
Net Income Growth
12.09 %
Cash Flow Change
-13.50 %
ROE
-0.64 %
ROCE
-1.87 %
EBITDA Margin (Avg.)
19.06 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
463
457
532
472
486
459
441
450
508
558
463
543
Expenses
385
371
441
385
405
374
352
353
388
459
364
409
EBITDA
78
86
91
87
81
85
89
97
120
99
98
134
Operating Profit %
16 %
19 %
17 %
18 %
16 %
19 %
20 %
21 %
23 %
17 %
20 %
24 %
Depreciation
14
14
17
16
16
17
18
19
19
20
21
23
Interest
5
4
6
5
6
4
4
5
5
5
6
10
Profit Before Tax
60
68
69
65
59
64
67
74
96
74
72
101
Tax
11
16
18
17
16
17
15
21
31
18
17
27
Net Profit
49
52
51
48
43
47
52
53
65
56
55
74
EPS in ₹
5.39
5.72
5.64
5.26
4.73
5.20
5.72
5.82
7.20
6.12
6.03
8.16

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
0
2,040
2,244
2,582
Fixed Assets
0
782
926
1,033
Current Assets
0
1,028
1,163
1,346
Capital Work in Progress
0
187
102
137
Investments
0
32
87
107
Other Assets
0
1,038
1,130
1,305
Total Liabilities
0
2,040
2,244
2,582
Current Liabilities
0
581
601
694
Non Current Liabilities
0
73
85
131
Total Equity
0
1,387
1,559
1,757
Reserve & Surplus
0
1,341
1,513
1,712
Share Capital
0
0
45
45

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
0
78
-71
12
Investing Activities
0
-139
-158
-215
Operating Activities
0
-44
250
216
Financing Activities
0
260
-164
10

Share Holding

% Holding
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
44.16 %
45.98 %
45.98 %
46.30 %
46.46 %
46.46 %
46.46 %
46.10 %
44.66 %
44.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
8.16 %
8.32 %
7.06 %
7.38 %
8.64 %
7.36 %
DIIs
14.73 %
13.70 %
10.66 %
10.51 %
9.91 %
9.97 %
11.47 %
11.35 %
10.36 %
7.53 %
Government
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
24.66 %
28.35 %
30.23 %
29.13 %
29.74 %
29.71 %
29.57 %
29.45 %
30.39 %
34.10 %
Others
16.44 %
11.96 %
13.12 %
14.04 %
5.72 %
5.52 %
5.43 %
5.71 %
5.94 %
6.71 %
No of Share Holders
3,05,456
2,76,664
2,58,236
2,26,286
2,15,796
2,04,122
1,89,012
1,85,436
1,85,111
1,96,314

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 3 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.46 0.4 0.00

Corporate Action

Announcements

Board Meeting Intimation for Audited Financial Results For The Year Ended March 31 2025 And Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025.1 day ago
Intimation Of Change In Email And Website Address Of Registrar And Share Transfer Agent (RTA)8 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Announcement under Regulation 30 (LODR)-Joint VentureApr 01, 2025
Announcement under Regulation 30 (LODR)-Joint VentureApr 01, 2025
Closure of Trading WindowMar 20, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 10, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2025
Record Date For Interim DividendFeb 05, 2025
Corporate Action-Board to consider DividendFeb 05, 2025
Integrated Filing (Financial)Feb 05, 2025
Financial Results For Quarter Ended December 31 2024Feb 05, 2025
Board Meeting Outcome for Financial Results For Quarter Ended December 31 2024Feb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2025
Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2024 And 2. Declaration Of Interim Dividend If Any On The Equity Share Capital OJan 28, 2025
Re-Opening Of Manufacturing Activities At The CompanyS Vapi PlantJan 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 09, 2025
Closure Of Manufacturing Activities At The CompanyS Vapi PlantJan 03, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 30, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 30, 2024
Disclosure under Regulation 30A of LODRDec 17, 2024
Board Meeting Outcome for Outcome Of Board MeetingDec 13, 2024
Appointment of Company Secretary and Compliance OfficerDec 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 10, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 28, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerOct 28, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 28, 2024
Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 28, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 21, 2024
Board Meeting Intimation for Financial Results For Quarter And Half Year Ended September 30, 2024Oct 21, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Closure of Trading WindowSep 26, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 09, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 08, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 08, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 07, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 06, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationAug 05, 2024
Financial Results For The Quarter Ended June 30, 2024Aug 05, 2024
Board Meeting Outcome for OUTCOME OF THE BOARD MEETINGAug 05, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2024

Technical Indicators

RSI(14)
Neutral
52.31
ATR(14)
Volatile
42.45
STOCH(9,6)
Neutral
78.13
STOCH RSI(14)
Neutral
62.65
MACD(12,26)
Bullish
4.77
ADX(14)
Weak Trend
11.68
UO(9)
Bearish
58.20
ROC(12)
Uptrend And Accelerating
5.65
WillR(14)
Neutral
-34.77